For ESRD subjects on hemodialysis, hourly blood samples (some of which were in addition to those mentioned above) were drawn during each of the first two hemodialysis sessions post-administration (each hemodialysis session lasted for ~24 h)
Concurrently, an increase in adiponectin, an anti-inflammatory adipokine, was observed, suggesting a reprogramming of adipocyte secretion toward a protective phenotype
After multiple attempts to get her insurance company to cover the drug (shed been prescribed it for weight management but her insurer said the drug was too new to cover), she had to stop taking it
Those checks matter, yet the two numbers40 and 35remain the gatekeepers
In the Phase II trial, 73% to 94% of participants reported side effects with retatrutide, especially at the higher doses of 8 mg and 12 mg once weekly